Cargando…
Splanchnic vein thrombosis associated with SARS-CoV-2 infection: A VALDIG case–control study
BACKGROUND & AIMS: Whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is a risk factor for splanchnic vein thrombosis (SVT) is unknown. This study aims to assess the impact of SARS-CoV-2 infection on the presentation and prognosis of recent SVT and to identify specifi...
Autores principales: | Deltenre, Pierre, Payancé, Audrey, Elkrief, Laure, Mura, Vincenzo La, Artru, Florent, Baiges, Anna, Cervoni, Jean-Paul, China, Louise, Colle, Isabelle, Lemaitre, Elise, Procopet, Bogdan, Schiller, Dietmar, Bureau, Christophe, Goria, Odile, Ollivier, Isabelle, Nuzzo, Alexandre, Rautou, Pierre-Emmanuel, Plessier, Aurélie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570588/ https://www.ncbi.nlm.nih.gov/pubmed/37841638 http://dx.doi.org/10.1016/j.jhepr.2023.100894 |
Ejemplares similares
-
Management of splanchnic vein thrombosis
por: Elkrief, Laure, et al.
Publicado: (2023) -
New cases of Budd-Chiari syndrome and splanchnic vein thrombosis after COVID-19 vaccination-a vascular liver disease group (VALDIG) initiative
por: Maan, Raoel, et al.
Publicado: (2022) -
Hepatobiliary MR contrast agents are useful to diagnose hepatocellular carcinoma in patients with Budd-Chiari syndrome
por: Van Wettere, Morgane, et al.
Publicado: (2020) -
Hepatic venous pressure gradient in sinusoidal obstruction syndrome: diagnostic value and link with histological lesions
por: Gressens, Simon B., et al.
Publicado: (2022) -
Impact of SARS-CoV-2 Pandemic on Vascular Liver Diseases
por: Baiges, Anna, et al.
Publicado: (2022)